OMV and Kommunalkredit Austria – a bank specializing in infrastructure and energy financing – are investing in the construction of Austria’s largest electrolysis plant to...
Sandoz, the generics division of Swiss drugmaker Novartis, is picking up GlaxoSmithKline’s cephalosporin antibiotics business, including the brands Zinnat, Zinacef and...
The IIoT continues to evolve, with countless solutions touting end-to-end process automation. However, one of the most important elements of IIoT — the human element —...
US-based CDMO Regis Technologies has completed a major expansion of its laboratory facilities for development of active pharmaceutical ingredients (APIs) at its site in...
US biopharma AbbVie and compatriot biotech Caribou Biosciences have entered into a multi-year collaboration and license agreement to research and develop chimeric antigen...
Spanish energy and petrochemical group Repsol has signed a licensing agreement for its propylene oxide/styrene monomer (PO/SM) and polyols technologies for three plants...
PolyPeptide Group has appointed Raymond De Vré as its new Chief Executive Officer (CEO). He will succeed Jane Salik who, after 15 years in this position, will concentrate...
Schrödinger Scientists share a birds-eye view of how modern in-silico approaches are being used to solve challenging design problems and leveraging collective ideation in...
US chemical company Chemours announced on Feb. 11 that it had split its Fluoroproducts segment into two distinct businesses during the fourth quarter of 2020.
The World Health Organization (WHO) has granted emergency use authorization (EUA) to the AstraZeneca/ Oxford University coronavirus vaccine, in an attempt to distribute...
